ITGB4 and ovarian carcinoma: Meanwhile, higher mRNA expression of ITGA3 and ITGB4/8 were significantly associated with poor PFS, lower mRNA expression of ITGA4/A6/A7/A10/AX and ITGB1 were significantly associated with poor PFS in ovarian cancer patients (Figures 3L–T).